121 related articles for article (PubMed ID: 8080533)
1. Cost effectiveness of interferon in chronic active hepatitis C.
Sallie R
Med J Aust; 1994 Jul; 161(2):169-70. PubMed ID: 8080533
[No Abstract] [Full Text] [Related]
2. Cost effectiveness of interferon in chronic active hepatitis C.
Turnbull C; Sugano D
Med J Aust; 1994 Jul; 161(2):169; author reply 170. PubMed ID: 8028544
[No Abstract] [Full Text] [Related]
3. [Cost-effectiveness analysis of the treatment of chronic hepatitis C].
Joliot E; Vanlemmens C; Kerleau M; Le Gales C; Woronoff-Lemsi MC; Flori YA; Seror V; Hrusovsky S; Monnet E; Bresson-Hadni S; Miguet JP
Gastroenterol Clin Biol; 1996; 20(11):958-67. PubMed ID: 9119185
[TBL] [Abstract][Full Text] [Related]
4. The cost effectiveness of alpha interferon in the treatment of chronic active hepatitis C.
Shiell A; Briggs A; Farrell GC
Med J Aust; 1994 Mar; 160(5):268-72. PubMed ID: 8107627
[TBL] [Abstract][Full Text] [Related]
5. [Compared efficiency of three strategies of management of chronic hepatitis C. Effect on the risk of cirrhosis 8 years after diagnosis].
Michel P; Merle V; Gourier C; Hochain P; Colin R; Czernichow P
Gastroenterol Clin Biol; 1996 Feb; 20(1):47-54. PubMed ID: 8734312
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of chronic viral hepatitis].
Marcellin P; Metreau JM; Pol S; Zoulim F
Ann Gastroenterol Hepatol (Paris); 1996; 32(2):85-7. PubMed ID: 8737503
[No Abstract] [Full Text] [Related]
7. The treatment of chronic viral hepatitis.
Hoofnagle JH; di Bisceglie AM
N Engl J Med; 1997 Jan; 336(5):347-56. PubMed ID: 9011789
[No Abstract] [Full Text] [Related]
8. [Medico-economic assessment of the therapeutic management of patients with hepatitis C].
Loubière S; Rotily M; Moatti JP
Gastroenterol Clin Biol; 2000 Nov; 24(11):1047-51. PubMed ID: 11139674
[TBL] [Abstract][Full Text] [Related]
9. Case report: development of hepatocellular carcinoma in a patient with chronic hepatitis C infection after a complete and sustained response to interferon-alpha.
Hirashima N; Mizokami M; Orito E; Koide T; Itazu I; Kumada K; Sakakibara K; Kano H; Lau JY
J Gastroenterol Hepatol; 1996 Oct; 11(10):955-8. PubMed ID: 8912134
[TBL] [Abstract][Full Text] [Related]
10. [The successful treatment of chronic active hepatitis due to hepatitis C viral infection with alpha-interferon and a cytokine complex (a clinical case)].
Karpov VV; Krel' PE
Ter Arkh; 1995; 67(5):84-5. PubMed ID: 7638792
[No Abstract] [Full Text] [Related]
11. [Case of hepatocellular carcinoma due to interferon therapy of chronic hepatitis C].
Enomura H; Ogasawara M; Doi K; Endo T; Mori T; Matsuzaki O; Fujimoto Y; Takase K; Nakano T
Nihon Naika Gakkai Zasshi; 1997 Oct; 86(10):1961-3. PubMed ID: 9445884
[No Abstract] [Full Text] [Related]
12. [Therapy of chronic hepatitis B, C and D with alpha-interferon].
Niederau C
Fortschr Med; 1993 Feb; 111(6):35-7. PubMed ID: 8462911
[No Abstract] [Full Text] [Related]
13. [Therapy of acute and chronic viral hepatitis C (non-A, non-B) with interferon-alpha].
Alscher DM; Bode JC
Med Klin (Munich); 1992 Oct; 87(10):532-9. PubMed ID: 1461219
[No Abstract] [Full Text] [Related]
14. [Predictive factors of response to interferon-alpha treatment in chronic hepatitis C].
Buti M; Esteban R
Rev Esp Enferm Dig; 1997 Jul; 89(7):501-2. PubMed ID: 9303619
[No Abstract] [Full Text] [Related]
15. Chronic hepatitis C and markedly elevated serum alpha-fetoprotein: complete response to treatment with alpha-interferon.
Weinberg DS; Malet PF
Am J Gastroenterol; 1994 Aug; 89(8):1253-4. PubMed ID: 7519819
[No Abstract] [Full Text] [Related]
16. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C.
Glück T; Seelig R; Dette S; Bühring HJ; Renz M; Kwon S; Wiedmann KH; Weber P
Hepatogastroenterology; 1997; 44(14):484-91. PubMed ID: 9164523
[TBL] [Abstract][Full Text] [Related]
17. alpha-Interferon therapy for hepatitis C virus chronic infection with mixed cryoglobulinemia.
Castilla A; Castilla I; Prieto J
Am J Gastroenterol; 1993 Mar; 88(3):466-7. PubMed ID: 8438868
[No Abstract] [Full Text] [Related]
18. [Factors of response to treatment with interferon-alpha in patients with chronic hepatitis C. Therapeutic perspectives].
Marcellin P; Pouteau M; Martinot M; Boyer N; Castelnau C; Benhamou JP; Erlinger S
Gastroenterol Clin Biol; 1995 Dec; 19(12):991-1000. PubMed ID: 8729410
[No Abstract] [Full Text] [Related]
19. Hepatocellular carcinoma developed in a patient with chronic hepatitis C after the disappearance of hepatitis C virus due to interferon therapy.
Inoue M; Ohhira M; Ohtake T; Matsumoto A; Kawashima T; Fujimoto Y; Hasebe C; Ono M; Kohgo Y
Hepatogastroenterology; 1999; 46(28):2554-60. PubMed ID: 10522040
[TBL] [Abstract][Full Text] [Related]
20. [What are the indications for interferon therapy with regard to the significance of serologic and histologic findings and laboratory data?].
Gerken G
Internist (Berl); 1993 Nov; 34(11):1062-5. PubMed ID: 8282492
[No Abstract] [Full Text] [Related]
[Next] [New Search]
